Screening Strategies in Drug Discovery – Products

Creative Peptides has enhanced its peptide library construction and screening services, incorporating advanced technologies like high-throughput screening, phage, and mRNA display to speed up drug discovery.

Metrion Biosciences launches a validated NaV1.9 screening assay to advance non-opioid pain therapeutic development.

Amsbio has launched a new range of 96-well Deubiquitinating (DUB) enzyme assay kits for high-throughput screening. The kits are designed to measure DUB enzyme activity and screen inhibitors in cell-based models and purified enzyme systems.

Azenta Life Sciences introduces the Automated Plate Seal Remover, a system designed to efficiently remove microplate seals. Capable of processing up to 200 plates per hour, it improves workflow automation and reduces contamination risk.

This article reviews pathological and physiological role of Tau proteins in neurodegeneration, Tau-targeted drug development strategies, and SignalChem’s contribution

The PHERAstar FSX is BMG LABTECH’s most sensitive multi-mode reader for high-throughput screening, combining this sensitivity with fast read times

SignalChem Biotech, part of Sino Biological, offers one of the largest active enzyme collections in the world and specializes in comprehensive in vitro compound screening services, from low to medium throughput

This application note demonstrates how combining live-cell analysis with high-throughput screening cytometry enables continuous, non-invasive monitoring of MSC differentiation, offering unprecedented insights into cellular dynamics while preserving

CryoLogyx LTD., a startup that specialises in cryopreserved cells and cryopreservation technology based in Coventry, United Kingdom, has been named a finalist competing for Ignite Award at SLAS2025 International Conference & Exhibition in San Diego.

The modular, high-throughput solution captures exceptional imagery from diverse samples and extracts new insights using AI-driven analysis.